162 related articles for article (PubMed ID: 31671695)
1. The Oncogene AF1Q is Associated with WNT and STAT Signaling and Offers a Novel Independent Prognostic Marker in Patients with Resectable Esophageal Cancer.
Gruber ES; Oberhuber G; Birner P; Schlederer M; Kenn M; Schreiner W; Jomrich G; Schoppmann SF; Gnant M; Tse W; Kenner L
Cells; 2019 Oct; 8(11):. PubMed ID: 31671695
[TBL] [Abstract][Full Text] [Related]
2. AF1q Expression Associates with CD44 and STAT3 and Impairs Overall Survival in Adenoid Cystic Carcinoma of the Head and Neck.
Kadletz LC; Brkic FF; Jank BJ; Schneider S; Cede J; Seemann R; Gruber ES; Gurnhofer E; Heiduschka G; Kenner L
Pathol Oncol Res; 2020 Apr; 26(2):1287-1292. PubMed ID: 31273546
[TBL] [Abstract][Full Text] [Related]
3. AF1q is a novel TCF7 co-factor which activates CD44 and promotes breast cancer metastasis.
Park J; Schlederer M; Schreiber M; Ice R; Merkel O; Bilban M; Hofbauer S; Kim S; Addison J; Zou J; Ji C; Bunting ST; Wang Z; Shoham M; Huang G; Bago-Horvath Z; Gibson LF; Rojanasakul Y; Remick S; Ivanov A; Pugacheva E; Bunting KD; Moriggl R; Kenner L; Tse W
Oncotarget; 2015 Aug; 6(24):20697-710. PubMed ID: 26079538
[TBL] [Abstract][Full Text] [Related]
4. CD44, SHH and SOX2 as novel biomarkers in esophageal cancer patients treated with neoadjuvant chemoradiotherapy.
Honing J; Pavlov KV; Mul VE; Karrenbeld A; Meijer C; Faiz Z; Smit JK; Hospers GA; Burgerhof JG; Kruyt FA; Kleibeuker JH; Plukker JT
Radiother Oncol; 2015 Oct; 117(1):152-8. PubMed ID: 26364884
[TBL] [Abstract][Full Text] [Related]
5. CXCR2 expression and postoperative complications affect long-term survival in patients with esophageal cancer.
Nishi T; Takeuchi H; Matsuda S; Ogura M; Kawakubo H; Fukuda K; Nakamura R; Takahashi T; Wada N; Saikawa Y; Omori T; Kitagawa Y
World J Surg Oncol; 2015 Aug; 13():232. PubMed ID: 26231560
[TBL] [Abstract][Full Text] [Related]
6. MLLT11/AF1q boosts oncogenic STAT3 activity through Src-PDGFR tyrosine kinase signaling.
Park J; Kim S; Joh J; Remick SC; Miller DM; Yan J; Kanaan Z; Chao JH; Krem MM; Basu SK; Hagiwara S; Kenner L; Moriggl R; Bunting KD; Tse W
Oncotarget; 2016 Jul; 7(28):43960-43973. PubMed ID: 27259262
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of preoperative lymphocyte-monocyte ratio in patients with resectable esophageal squamous cell carcinoma.
Han LH; Jia YB; Song QX; Wang JB; Wang NN; Cheng YF
Asian Pac J Cancer Prev; 2015; 16(6):2245-50. PubMed ID: 25824745
[TBL] [Abstract][Full Text] [Related]
8. Mucin 1 and vascular endothelial growth factor C expression correlates with lymph node metastatic recurrence in patients with N0 esophageal cancer after Ivor-Lewis esophagectomy.
Sun ZG; Wang Z; Liu XY; Liu FY
World J Surg; 2011 Jan; 35(1):70-7. PubMed ID: 21046381
[TBL] [Abstract][Full Text] [Related]
9. AF1q Mediates Tumor Progression in Colorectal Cancer by Regulating AKT Signaling.
Hu J; Li G; Liu L; Wang Y; Li X; Gong J
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28475127
[TBL] [Abstract][Full Text] [Related]
10. Involvement of AF1q/MLLT11 in the progression of ovarian cancer.
Tiberio P; Lozneanu L; Angeloni V; Cavadini E; Pinciroli P; Callari M; Carcangiu ML; Lorusso D; Raspagliesi F; Pala V; Daidone MG; Appierto V
Oncotarget; 2017 Apr; 8(14):23246-23264. PubMed ID: 28423573
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Outcome of Esophagectomy Versus Nonsurgical Treatment for Resectable Esophageal Cancer with Clinical Complete Response to Neoadjuvant Therapy.
Ohkura Y; Shindoh J; Ueno M; Iizuka T; Udagawa H
Ann Surg Oncol; 2018 Aug; 25(8):2428-2433. PubMed ID: 29564587
[TBL] [Abstract][Full Text] [Related]
12. REG1A expression status suggests chemosensitivity among advanced thoracic esophageal squamous cell carcinoma patients treated with esophagectomy followed by adjuvant chemotherapy.
Sato Y; Motoyama S; Nanjo H; Ito S; Yoshino K; Sasaki T; Kuribayashi K; Nagaki Y; Imai K; Saito H; Minamiya Y; Ogawa J
Ann Surg Oncol; 2013 Sep; 20(9):3044-51. PubMed ID: 23645481
[TBL] [Abstract][Full Text] [Related]
13. Preoperative Glasgow Prognostic Score as additional independent prognostic parameter for patients with esophageal cancer after curative esophagectomy.
Lindenmann J; Fink-Neuboeck N; Avian A; Pichler M; Habitzruther M; Maier A; Smolle-Juettner FM
Eur J Surg Oncol; 2017 Feb; 43(2):445-453. PubMed ID: 27839896
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of the Circumferential Resection Margin in Esophageal Cancer Patients After Neoadjuvant Chemoradiotherapy.
Hulshoff JB; Faiz Z; Karrenbeld A; Kats-Ugurlu G; Burgerhof JG; Smit JK; Plukker JT
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1301-9. PubMed ID: 26314875
[TBL] [Abstract][Full Text] [Related]
15. Novel AF1q/MLLT11 favorably affects imatinib resistance and cell survival in chronic myeloid leukemia.
Li W; Ji M; Lu F; Pang Y; Dong X; Zhang J; Li P; Ye J; Zang S; Ma D; Ji C
Cell Death Dis; 2018 Aug; 9(9):855. PubMed ID: 30154435
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of surgical resection for the recurrence of esophageal cancer after radical esophagectomy.
Hiyoshi Y; Morita M; Kawano H; Otsu H; Ando K; Ito S; Miyamoto Y; Sakamoto Y; Saeki H; Oki E; Ikeda T; Baba H; Maehara Y
Ann Surg Oncol; 2015 Jan; 22(1):240-6. PubMed ID: 25124469
[TBL] [Abstract][Full Text] [Related]
17. Elevated expression of the AF1q gene, an MLL fusion partner, is an independent adverse prognostic factor in pediatric acute myeloid leukemia.
Tse W; Meshinchi S; Alonzo TA; Stirewalt DL; Gerbing RB; Woods WG; Appelbaum FR; Radich JP
Blood; 2004 Nov; 104(10):3058-63. PubMed ID: 15217837
[TBL] [Abstract][Full Text] [Related]
18. Expression status of CD44 and CD133 as a prognostic marker in esophageal squamous cell carcinoma treated with neoadjuvant chemotherapy followed by radical esophagectomy.
Okamoto K; Ninomiya I; Ohbatake Y; Hirose A; Tsukada T; Nakanuma S; Sakai S; Kinoshita J; Makino I; Nakamura K; Hayashi H; Oyama K; Inokuchi M; Nakagawara H; Miyashita T; Hidehiro T; Takamura H; Fushida S; Ohta T
Oncol Rep; 2016 Dec; 36(6):3333-3342. PubMed ID: 27748881
[TBL] [Abstract][Full Text] [Related]
19. Large-scale comprehensive immunohistochemical biomarker analyses in esophageal squamous cell carcinoma.
Hatogai K; Fujii S; Kojima T; Daiko H; Nomura S; Doi T; Kitano S; Ohtsu A; Takiguchi Y; Yoshino T; Ochiai A
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2351-2361. PubMed ID: 28756492
[TBL] [Abstract][Full Text] [Related]
20. Chromobox 2 Expression Predicts Prognosis After Curative Resection of Oesophageal Squamous Cell Carcinoma.
Ueda S; Kanda M; Sato Y; Baba H; Nakamura S; Sawaki K; Shimizu D; Motoyama S; Fujii T; Kodera Y; Nomoto S
Cancer Genomics Proteomics; 2020; 17(4):391-400. PubMed ID: 32576584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]